Consumer organization Which? released analysis comparing premium menopause supplements to standard multivitamins, finding significant disparities in both cost and nutritional content. The investigation examined 26 popular supplements sold through major retailers including Holland & Barrett, Boots, and Amazon, assessing their ingredient profiles and formulations.
Researchers identified calcium and vitamin D as crucial nutrients during perimenopause and menopause due to their role in supporting bone health as estrogen levels decline. Additional nutrients including iron and magnesium were noted as potentially helpful for managing symptoms. However, examination revealed that none of the supplements studied contained the appropriate nutrients in sufficient quantities to substantiate their marketed menopause-specific claims.
Price comparisons highlighted substantial cost differences for comparable or inferior nutritional profiles. Asda’s A-Z Multivitamins & Minerals, priced at £22 annually, provided comprehensive essential vitamins alongside calcium and magnesium. In contrast, premium products commanded significantly higher prices—Love Mushrooms’ Empower at £485 yearly and Wild Nutrition’s Women’s 45+ at £468 annually—while containing lower quantities of key menopause-related nutrients than the budget alternative. The highest-rated menopause-specific product examined, Vitabiotics’ Menopace Max at £340 annually, still cost substantially more than conventional multivitamins.
Which? concluded that combining a high-quality standard multivitamin with targeted supplements addressing specific deficiencies represented a more economical and potentially more effective approach than purchasing branded menopause blends. The organization expressed concerns about industry marketing practices and regulatory oversight, characterizing the supplements sector as lacking adequate supervision. A separate University College London study of 201 UK supplements found fewer than half contained vitamin D and calcium, with most ingredients lacking recommendations from major menopause medical societies.
Industry representatives responded that manufacturers follow applicable food regulations and that certain life stages may increase nutritional requirements. The global menopause supplement market was valued at approximately $17 billion with projections to reach $25 billion by 2030.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI